Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
Continental AG Shares Jump After Q1 Profit Beats Expectations 
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal 
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain 
China Banks Halt New Loans to Sanctioned Refineries Amid U.S.-Iran Oil Crackdown 
JD Sports Backs Nike CEO Elliott Hill Amid Brand Turnaround Efforts 
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations 
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert 
BHP Attracts AI-Focused Investors as Copper Demand Surges 
Arm Stock Drops Despite Strong AI Chip Demand and Earnings Beat 
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles 
Lufthansa Q1 Loss Narrows as Strong Summer Travel Demand Boosts Outlook 
Samsung Surpasses $1 Trillion Market Cap Amid AI Chip Boom and Apple Partnership Talks 
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom 
DUBLIN, IRELAND, May 01, 2018 -- Horizon Pharma plc (NASDAQ:HZNP), today announced that the company will participate in the following conference in May:
UBS Global Healthcare Conference
- Date: May 22, 2018
- Presentation Time: 9:30 a.m. ET
- Location: New York
The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for the event.
About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.
| Contacts: | |
| Investors: Tina Ventura Senior Vice President, Investor Relations [email protected] | U.S. Media: Geoff Curtis Senior Vice President, Corporate Affairs & Chief Communications Officer [email protected] |
| Ruth Venning Executive Director, Investor Relations [email protected] | Ireland Media: Ray Gordon Gordon MRM [email protected] |
